Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Bicalutamide may reduce hair shedding in women but needs longer trials to confirm its effectiveness.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

High androgen levels often cause female hirsutism and infertility.

Testosterone treatment for older men can have short-term benefits, but long-term risks are unclear, requiring careful evaluation and monitoring.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

A woman's severe hirsutism was caused by Leydig cell tumors in her ovaries, which improved after surgery.

Selective non-steroidal inhibitors of 5α-reductase type 1 can help treat DHT-related disorders.

Finasteride and dutasteride effectively reduce DHT in hair, which may help evaluate their treatment success for hair loss.

Treating PCOS patients with HP HMG significantly raises the risk of ovarian hyperstimulation syndrome, needing careful dose management.

Following national healthy eating guidelines can help reduce risks from gender-affirming hormone therapy.

Surgical removal of a rare ovarian tumor improved symptoms and hormone levels in a postmenopausal woman.

THSG from a Chinese plant helps with aging and related diseases.

Spironolactone may reduce excessive hair growth in women but its effectiveness for acne is not supported.

Androgens and SARMs play a role in body mass, frailty, skin health, and hair growth, and are used in treating prostate cancer, acne, and hair loss, with potential for new uses and improved versions in the future.

Hormonal treatments can change hair and skin in transgender people, but may not fully achieve desired results.

Norgestimate is the most effective birth control progestin for reducing an enzyme linked to acne and excessive hair growth in women.

Dihydrotestosterone (DHT) promotes the growth and spread of aggressive brain tumor cells.

Hormone treatments for transgender individuals generally improve mental health and physical transition, with some health risks that require medical supervision.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

The compound (1R,2S)-4-(2-Cyano-cyclohexyl-oxy)-2-trifluoromethyl-benzonitrile can stimulate hair growth and reduce oil production when applied topically.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.

Removing the ovarian tumor improved the woman's hormonal symptoms.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Genetic profiling can improve androgenetic alopecia treatment by predicting drug response and minimizing side effects.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

New compounds show promise for treating hair loss, enlarged prostate, and prostate cancer, with some being more effective and having different side effects than current treatments.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.